Skip to main content

Error message

Warning: Undefined array key "PANTHEON_ENVIRONMENT" in arentfox_preprocess_html() (line 15 of themes/custom/arentfox/arentfox.theme).
arentfox_preprocess_html()
call_user_func_array() (Line: 261)
Drupal\Core\Theme\ThemeManager->render() (Line: 491)
Drupal\Core\Render\Renderer->doRender() (Line: 248)
Drupal\Core\Render\Renderer->render() (Line: 158)
Drupal\Core\Render\MainContent\HtmlRenderer->Drupal\Core\Render\MainContent\{closure}() (Line: 638)
Drupal\Core\Render\Renderer->executeInRenderContext() (Line: 153)
Drupal\Core\Render\MainContent\HtmlRenderer->renderResponse() (Line: 90)
Drupal\Core\EventSubscriber\MainContentViewSubscriber->onViewRenderArray()
call_user_func() (Line: 111)
Drupal\Component\EventDispatcher\ContainerAwareEventDispatcher->dispatch() (Line: 186)
Symfony\Component\HttpKernel\HttpKernel->handleRaw() (Line: 76)
Symfony\Component\HttpKernel\HttpKernel->handle() (Line: 53)
Drupal\Core\StackMiddleware\Session->handle() (Line: 48)
Drupal\Core\StackMiddleware\KernelPreHandle->handle() (Line: 28)
Drupal\Core\StackMiddleware\ContentLength->handle() (Line: 201)
Drupal\page_cache\StackMiddleware\PageCache->fetch() (Line: 138)
Drupal\page_cache\StackMiddleware\PageCache->lookup() (Line: 87)
Drupal\page_cache\StackMiddleware\PageCache->handle() (Line: 50)
Drupal\ban\BanMiddleware->handle() (Line: 48)
Drupal\Core\StackMiddleware\ReverseProxyMiddleware->handle() (Line: 51)
Drupal\Core\StackMiddleware\NegotiationMiddleware->handle() (Line: 36)
Drupal\Core\StackMiddleware\AjaxPageState->handle() (Line: 51)
Drupal\Core\StackMiddleware\StackedHttpKernel->handle() (Line: 741)
Drupal\Core\DrupalKernel->handle() (Line: 19)
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Life Sciences

Insights on Life Sciences

344 total results. Page 1 of 14.

Health Care Counsel Blog
FDA’s Attempt to Regulate Lab-Developed Tests Struck Down in Federal Court
April 9, 2025
Emily Cowley Leongini, Wayne H. Matelski, Jack R. Bierig, Gayland O. Hethcoat II

On March 31, a judge in the Eastern District of Texas vacated the US Food and Drug Administration’s (FDA) rule that sought to regulate laboratory-developed tests (LDTs) as medical devices under the Federal Food, Drug, and Cosmetic Act (FDCA).

Alerts
FDA Finds Significant Bioequivalence Concerns in Raptim Studies Leading to ANDA and NDA Reviews
April 2, 2025
Wayne H. Matelski

In a highly unusual move, on March 27, the US Food and Drug Association (FDA) issued a Drug Safety Notice that calls into question both pending and approved abbreviated new drug applications (ANDAs) and new drug applications (NDAs) that relied on bioequivalence studies conducted by Raptim Research Pvt. Ltd, a contract research organization based in Navi Mumbai, India.

Events
BPIA 2025 Annual Meeting
April 2, 2025
Stanley H. Abramson

Stan Abramson will speak on the Legal Liability Panel at the Biological Products Industry Alliance’s (BPIA) 2025 Annual Meeting in Sacramento, California, on April 2, 2025. His work is focused on chemical, biological, and biotechnology products for agricultural, industrial, and consumer use.

Press Release
ArentFox Schiff Shortlisted for Managing IP Americas Awards 2025
March 31, 2025

ArentFox Schiff is pleased to announce that the firm and Partner James J. Bindseil have been shortlisted for the annual Managing IP (MIP) Americas Awards.

Events
Regulatory Issues for Life Sciences Companies in 2025
February 27, 2025
Philip S. English*, David R. Hamill, Wayne H. Matelski, Stephanie Trunk, Brian P. Waldman, Joy Marie Virga*

ArentFox Schiff professionals will discuss recent matters that directly impact the life sciences industry and its trajectory.

Investigations Blog
First Circuit Joins Sixth and Eighth Circuits in Adopting Heightened, But-For Causation Standard for AKS-Based FCA Claims
February 21, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Pascal Naples, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
Top Legal Challenges for the Health Care Industry in 2025
February 20, 2025
David S. Greenberg, Douglas A. Grimm, Annie Chang Lee, Michele L. Gipp, Anne M. Murphy, Stephanie Trunk, Hillary M. Stemple, Gayland O. Hethcoat II, D. Jacques Smith, Daniel J. McQueen, Jeffrey B. Tate , Brian D. Schneider, Moyosore O. Koya, William R. Mitchell, Rebekkah R.N. Stoeckler, Pascal Naples

With 2025 underway, the AFS Health Care team highlights some of the most pressing legal issues facing the health care industry this year.

Investigations Blog
Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million
January 31, 2025
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Roberto Martinez, Apeksha Vora

Headlines that Matter for Companies and Executives in Regulated Industries

AI Law Blog
FDA Issues New Recommendations on Use of AI for Medical Devices, Drugs, and Biologics
January 21, 2025
Dan Jasnow, Wayne H. Matelski, Shoshana Golden

In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued two draft guidances on the use of artificial intelligence (AI) in the context of drugs, biologics, and medical devices.

Investigations Blog
California Doctor to Pay $3 Million for Insider Trading
December 20, 2024
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Elizabeth Satarov, Apeksha Vora

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
Three Overhauls to Accelerated Drug Approval You Need to Know About: Novel Endpoints, Confirmatory Trials, and Expedited Withdrawal of Approvals
December 18, 2024
Aida Al-Akhdar, Emily Cowley Leongini, Shoshana Golden

Earlier this month, the US Food and Drug Administration (FDA) issued new draft guidance regarding their accelerated approval pathway for new drugs and biologics, an expedited program designed to help address unmet medical needs for serious or life-threatening conditions. As usual, the FDA is soliciting comments to the new guidance, due by February 4, 2025.

Investigations Blog
Florida Telemarketer Sentenced to 15 Years in Prison for $67 Million Medicare Fraud Scheme
December 13, 2024
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, M.H. Joshua Chiu, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Owner, Operator of Texas Lab Charged for $79 Million Medical Testing Fraud Scheme
November 22, 2024
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know
November 21, 2024
Stephanie Trunk, Shoshana Golden

This past July, we reported on the Centers for Medicare & Medicaid Services (CMS) release of the 2025 proposed Hospital Outpatient Prospective Payment System (HOPPS) and Physician Fee Schedule (PFS) rules. CMS has now released the 2025 final rules, though they will not be published in the Federal Register for several more weeks.

2024 Election Analysis
Alerts
ArentFox Schiff 2024 Election Analysis
November 7, 2024
Byron Dorgan*, Doug Jones, Philip S. English*, Dan H. Renberg, Jon S. Bouker, Craig Engle, David P. Grosso, David Tafuri, Cissy Jackson, Laura E. Doyle*, Oliver Spurgeon III*, Kelsey Griswold-Berger*, Daniel Sjostedt*, Starshine S. Chun*, Katherine Kramer*

The United States awoke on November 6 to a changed and improbable political landscape. The nation has re-elected Donald J. Trump as President and has given him a US Senate Republican majority and potentially a US House of Representatives Republican majority as well. As fatigued and steadfast local and state election workers continue to sort through ballots, we continue to look to the finalization of tallies for some remaining Senate and House races to determine the nature and size of Congressional majorities.

Investigations Blog
Teva Pharmaceuticals Agrees to Pay $450 Million to Resolve FCA Claims
October 18, 2024
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Rebecca W. Foreman, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Events
World Trademark Review’s Brand Strategy Summit USA
October 8, 2024
Marylee Jenkins

Partner Marylee Jenkins will attend the Brand Strategy Summit USA on October 8, where she will lead an interview titled “Advancing the Trademark System: A Behind-the-Scenes Look.”

Investigations Blog
Florida Federal Judge Strikes Down FCA’s Qui Tam Provision as Unconstitutional
October 4, 2024
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Mattie Bowden, Shoshana Golden, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
The 340B ‘Saga’ Continues: As More States Pass 340B Contract Pharmacy Laws, More Lawsuits Follow
September 3, 2024
Douglas A. Grimm, Stephanie Trunk, Gayland O. Hethcoat II, Shoshana Golden

In 2021, we provided an overview of multiple federal lawsuits challenging the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) enforcement of the 340B Drug Pricing Program, particularly with respect to contract pharmacies.

Press Release
ArentFox Schiff Shortlisted for LMG Life Sciences Americas Awards 2024
July 31, 2024

ArentFox Schiff is pleased to announce that the firm and three partners have been shortlisted for the annual LMG Life Sciences Americas Awards.

Health Care Counsel Blog
The 2025 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know
July 17, 2024
Stephanie Trunk, Shoshana Golden

Pharma’s favorite summer pastime is back again: reviewing the Centers for Medicare & Medicaid Services (CMS) release of the 2025 proposed Hospital Outpatient Prospective Payment System (HOPPS) and Physician Fee Schedule (PFS) rules.

Customs & Import Compliance Blog
As the (Customs and Trade) World Turns: June 2024
June 17, 2024
Angela M. Santos, David R. Hamill, Nancy A. Noonan, Antonio J. Rivera, Sylvia G. Costelloe, Derek Ha, James Kim*, Lucas A. Rock, Mario A. Torrico, Birgit Matthiesen

Welcome to the June 2024 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month.

Events
Webinar: Due Diligence for Life Science Companies
June 12, 2024
Stephanie Trunk, D. Jacques Smith

Join ArentFox Schiff Partners Stephanie Trunk, a recognized authority in government pricing and compliance, and Jacques Smith, a leading health care litigator with extensive experience guiding life science companies through government inquiries, as they share key insights and aim to equip participants with the knowledge to effectively manage due diligence in life science mergers and acquisitions.

Press Release
ArentFox Schiff Adds 17-Member Technology and Life Sciences Industry Team in Boston
June 11, 2024

ArentFox Schiff is pleased to announce the addition of 17 attorneys and specialists, including eight partners and three counsel, to its Boston office, expanding the firm’s nationally recognized Technology, Life Sciences, Intellectual Property, and Complex Litigation services.

Health Care Counsel Blog
New ADR Rule to Govern Disputes Between 340B Covered Entities and Drug Manufacturers
May 14, 2024
Douglas A. Grimm, Stephanie Trunk, Gayland O. Hethcoat II

Disputes between 340B Drug Pricing Program-covered entities and the drug manufacturers required to sell outpatient drugs to those entities at discounted prices will be governed by an alternative dispute resolution (ADR) process under a Final Rule published on April 19, by the US Department of Health and Human Services’ Health Resources and Services Administration (HRSA).

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

Back to Top